Vanzacaftor
| CAS No. | 2374124-49-7 | Cat. No. | BCP49728 |
| Name | Vanzacaftor | ||
| Synonyms | VX-121;VX 121;VX121; | ||
| Formula | C32H39N7O4S | M. Wt | 617.76 |
| Description | Vanzacaftor (VX-121) is an orally active noval corrector of Cystic fibrosis transmembrane conductance regulator (CFTR). Vanzacaftor improves processing and trafficking of CFTR protein as well as increases chloride transport in triple combined with Tezacaftor and Deutivacaftor. Vanzacaftor-Tezacaftor-Deutivacaftor is safe and well tolerated, improving lung function, respiratory symptoms, and CFTR function with cystic fibrosis, which is promising for research in the field of cystic fibrosis diseases. | ||
| Pathways | Ion Channel/Membrane Transporter | ||
| Targets | CFTR | ||
Structure
Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.
For product details of different batches, please contact our Customer
- Service & Tech Support:orders@biochempartner.com
- Website:www.biochempartner.com
Products are for research use only and not for human use. We do not sell to patients.